-
Board Certification
American Board of Internal MedicineAmerican Board of Internal Medicine (Sub: Medical Oncology)Patient Rating
4.9 /5( out of 109 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.June 29, 2024HUNTSMAN CANCER CENTERMy first visit Dr. Wei was perfect
June 13, 2024SUGAR HOUSE HEALTH CENTERMei wei It's a very excellent doctor
June 08, 2024HUNTSMAN CANCER CENTERDr Wei takes the time to listen and give her honest answers to questions that I have. I feel like we work well together.
June 01, 2024HUNTSMAN CANCER CENTERVery knowledgeable and caring
May 10, 2024HUNTSMAN CANCER CENTERI would highly recommend Dr. Wei to friends and family. She listens well to concerns and she explains the issues and the treatment options well.
May 09, 2024SUGAR HOUSE HEALTH CENTERDr. Wei is good and easy to work with. She is a great Dr.
April 30, 2024SUGAR HOUSE HEALTH CENTERAlways listens well to me and my concerns.
April 07, 2024HUNTSMAN CANCER CENTERMei Wei is wonderful kind patient understanding very blessed to have her as my doctor.
March 28, 2024SUGAR HOUSE HEALTH CENTERMei Wei is an exceptional doctor! I highly recommend her. She is careful, loving, respectful, appreciative, easy to talk to, and listens carefully. Thank you Dr. Wei!
-
Board Certification and Academic Information
Academic Departments Internal Medicine -Primary Academic Divisions Oncology
Board Certification American Board of Internal MedicineAmerican Board of Internal Medicine (Sub: Medical Oncology)Education history
Fellowship Hematology/Oncology - University of Utah School of Medicine Fellow Internal Medicine - University of Utah School of Medicine Resident Internship Internal Medicine - University of Nevada, Reno School of Medicine Intern Cancer Epidemiology - University of Utah School of Medicine Postdoctoral Research Fellow Residency Radiation Oncology - Sun Yat-sen University Cancer Center Resident Gynecological Oncology - Sun Yat-sen University Cancer Center Resident Professional Medical Medicine - Anhui Medical University M.D. Selected Publications
Journal Article
- Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Bailey J, Burstein HJ, Chen N, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, McCloskey S, McShane M, Mortimer J, Patel SA, Rosenberger LH, Rugo HS, Santa-Maria C, Schneider BP, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Yeung KT, Young JS, Schonfeld R, Kumar R (2024). Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(5), 331-357. (Read full article)
- Koric A, Chang CE, Lee YA, Wei M, Lee C, Tao R, Wang J, Tay D, Hashibe M (2024). Incident Diabetes among Older Asian, Native Hawaiian and Pacific Islander Women with Breast Cancer. JNCI Cancer Spectr. (Read full article)
- NCCN breast oncology panel (2024). NCCN clinical practice guidelines in oncology, Breast Cancer. Version 1.2024. J Natl Compr Canc Netw.
- Hashibe M, Wei M, Lee CJ, Tao R, Koric A, Wang J, Daud A, Tay D, Shen J, Lee YA, Chang CE (2023). Incident Cardiovascular Disease Risk among Older Asian, Native Hawaiian and Pacific Islander Breast Cancer Survivors. Cancer Epidemiol Biomarkers Prev, 33(1), 126-135. (Read full article)
- Covington MF, Hoffman JM, Morton KA, Buckway B, Boucher KM, Rosenthal RE, Porretta JM, Brownson KE, Matsen CB, Vaklavas C, Ward JH, Wei M, Buys SS, Chittoria N, Yakish ED, Archibald ZG, Burrell LD, Butterfield RI, Yap JT (2023). Prospective Pilot Study of (18)F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas. AJR Am J Roentgenol, 221(2), 228-239. (Read full article)
- Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, Mortimer J, Patel SA, Pierce LJ, Rosenberger LH, Rugo HS, Schneider B, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Young JS, Yeung K, Dwyer MA, Kumar R (2023). NCCN Guidelines® Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw, 21(6), 594-608. (Read full article)
- Kalra M, Henry E, McCann K, Karuturi MS, Bustamante Alvarez JG, Parkes A, Wesolowski R, Wei M, Mougalian SS, Durm G, Qin A, Schonewolf C, Trivedi M, Armaghani AJ, Wilson FH, Iams WT, Turk AA, Vikas P, Cecchini M, Lubner S, Pathak P, Spencer K, Koshkin VS, Labriola MK, Marshall CH, Beckermann KE, theMednetorg NCI-CCC Tumor Board Program Collaborative Group, Sharifi MN, Bejjani AC, Hotchandani V, Housri S, Housri N (2022). Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study. JMIR Cancer, 8(2), e33859. (Read full article)
- Sharma A, Johnson KB, Bie B, Rhoades EE, Sen A, Kida Y, Hockings J, Gatta A, Davenport J, Arcangelini C, Ritzu J, DeVecchio J, Hughen R, Wei M, Thomas Budd G, Lynn Henry N, Eng C, Foss J, Rotroff DM (2022). A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol. Technol Cancer Res Treat, 21, 15330338221127169. (Read full article)
- Wei M, Wang X, Zimmerman DN, Burt LM, Haaland B, Henry NL (2021). Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer. Breast Cancer Res Treat, 187(1), 287-294. (Read full article)
- Bernard PS, Wooderchak-Donahue W, Wei M, Bray SM, Wood KC, Parikh B, McMillin GA (2021). Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer. Cancers (Basel), 13(6). (Read full article)
- Gilreath JA, Wei M, Paul S, Parker CJ, Stenehjem DD, Rodgers GM (2018). Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports. J Oncol Pharm Pract, 25(3), 719-723. (Read full article)
- Raspanti GA, Hashibe M, Siwakoti B, Wei M, Thakur BK, Pun CB, Al-Temimi M, Lee YC, Sapkota A (2016). Household air pollution and lung cancer risk among never-smokers in Nepal. Environ Res, 147, 141-5. (Read full article)
- Raspanti GA, Hashibe M, Siwakoti B, Wei M, Thakur BK, Pun CB, Milrod C, Adhikari S, Lee YC, Sapkota A (2015). Ethnic Variation in Consumption of Traditional Tobacco Products and Lung Cancer Risk in Nepal. Asian Pac J Cancer Prev, 16(14), 5721-6. (Read full article)
Review
- Johnson KB, Sharma A, Henry NL, Wei M, Bie B, Hershberger CE, Rhoades EE, Sen A, Johnson RE, Steenblik J, Hockings J, Budd GT, Eng C, Foss J, Rotroff DM (2023). Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative review. [Review]. Front Pain Res (Lausanne), 4, 1139883. (Read full article)
Case Report
- Wei M, Maurer KA, Henry NL (2019). Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy. Breast J, 25(6), 1254-1256. (Read full article)
( out of 109 reviews )